Introducing Polyautoimmunity: Secondary Autoimmune Diseases No Longer Exist

Table 2

Significant factors associated with polyautoimmunity.

	SLE		RA		MS		SSc
	AOR; CI95%	𝑃	AOR; CI95%	𝑃	AOR; CI95%	𝑃	AOR; CI95%	𝑃
Female gender	2.3; 1.03–5.15	0.043	1.8; 1.22–6.31	0.015	8.5; 1.02–70.8	0.048	9.08; 2.09–39.3	0.003
Familial autoimmunity	1.61; 1.14–2.28	0.007	NS		NS		2.62; 1.24–5.54	0.01
Articular Involvement	2.02; 1.26–3.23	0.003	NS		NE		NS
Anti-Ro positivity	1.54; 1.10–2.16	0.013	NS		NE		NS
Cardiovascular disease	NS		2.2; 1.17–3.94	0.014	NE		NE
ANAs	NS		2.0; 1.08–3.84	0.027	NS
SSEP	NE		NE		10.86; 1.31–89.6	0.027	NE

SLE: systemic lupus erythematosus; RA: rheumatoid arthritis; MS: multiple sclerosis; SSc: systemic sclerosis; AOR: adjusted odd ratio; CI95%: confidence interval; ANAs: antinuclear antibodies; SSEP: somatosensory evoked potentials; NS: nonsignificant; NE: not evaluated.